key: cord-1041635-zd01ujyk
authors: Wang, Julia Y.; Zhang, Wei; Roehrl, Michael W.; Roehrl, Victor B.; Roehrl, Michael H.
title: An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19
date: 2021-04-27
journal: J Autoimmun
DOI: 10.1016/j.jaut.2021.102644
sha: 554e7bdd56769b68da77b8d625dbfd2168390b5e
doc_id: 1041635
cord_uid: zd01ujyk

We aim to establish a comprehensive COVID-19 autoantigen atlas in order to understand autoimmune diseases caused by SARS-CoV-2 infection. Based on the unique affinity between dermatan sulfate and autoantigens, we identified 348 proteins from human lung A549 cells, of which 198 are known targets of autoantibodies. Comparison with current COVID data identified 291 proteins that are altered at protein or transcript level in SARS-CoV-2 infection, with 191 being known autoantigens. These known and putative autoantigens are significantly associated with viral replication and trafficking processes, including gene expression, ribonucleoprotein biogenesis, mRNA metabolism, translation, vesicle and vesicle-mediated transport, and apoptosis. They are also associated with cytoskeleton, platelet degranulation, IL-12 signaling, and smooth muscle contraction. Host proteins that interact with and that are perturbed by viral proteins are a major source of autoantigens. Orf3 induces the largest number of protein alterations, Orf9 affects the mitochondrial ribosome, and they and E, M, N, and Nsp proteins affect protein localization to membrane, immune responses, and apoptosis. Phosphorylation and ubiquitination alterations by viral infection define major molecular changes in autoantigen origination. This study provides a large list of autoantigens as well as new targets for future investigation, e.g., UBA1, UCHL1, USP7, CDK11A, PRKDC, PLD3, PSAT1, RAB1A, SLC2A1, platelet activating factor acetylhydrolase, and mitochondrial ribosomal proteins. This study illustrates how viral infection can modify host cellular proteins extensively, yield diverse autoantigens, and trigger a myriad of autoimmune sequelae. Our work provides a rich resource for studies into “long COVID” and related autoimmune sequelae.

To gain better understanding of the transient and chronic autoimmune symptoms caused by SARS-CoV-2 infection, we have embarked on an endeavor to establish a comprehensive autoantigenome for COVID-19. We aim to provide a comprehensive resource and atlas for the investigation of autoimmune sequelae of COVID-19 ("long COVID"). In a previous study, we identified a repertoire of autoantigens (autoAgs) from human fetal lung fibroblast HFL1 cells that are strongly tied to neurological and diverse autoimmune symptoms of COVID-19 [1] . In this study, we aim to identify additional autoAgs from human lung epithelium-like A549 cells, an adenocarcinoma cell line that is frequently used as a model host in SARS-CoV-2 infection studies.

AutoAgs were identified based on the unique affinity between autoAgs and the glycosaminoglycan dermatan sulfate (DS) that we have discovered [2, 3] . AutoAgs and DS form affinity complexes that can engage strong dual BCR signaling in autoreactive B1 cells to induce autoantibody production [4] . Hence, any self-molecule capable of forming affinity complexes with DS has a high propensity to become autoantigenic. This unifying mechanism of autoantigenicity explains how seemingly unrelated selfmolecules can all induce autoimmune B cell responses via a similar immunological signaling event. Based on DS-autoAg affinity, we have cataloged several hundred autoAgs from various cells and tissues [1, [5] [6] [7] .

COVID-19 is accompanied by a wide range of autoimmune symptoms, including multisystem inflammatory syndrome in children, immune thrombocytopenic purpura, antiphospholipid syndrome, autoimmune cytopenia, immune-mediated neurological syndromes, Guillain-Barré syndrome, connective tissue disease-associated interstitial lung disease, autoimmune hemolytic anemia, autoimmune encephalitis, systemic lupus erythematosus, optic neuritis and myelitis, and acquired hemophilia [8] [9] [10] [11] [12] [13] [14] [15] . Numerous autoantibodies have been identified in COVID patients, including the classical ANA (antinuclear antibody) and ENA (extractable nuclear antigen) that are hallmarks of systemic autoimmune diseases, as well as others such as anti-neutrophil cytoplasmic antibody, lupus anticoagulant, antiphospholipid, anti-IFN, anti-myelin oligodendrocyte glycoprotein, and anti-heparin-PF4 complex antibodies [8] [9] [10] [11] [12] [13] [14] [15] .

SARS-CoV-2, or viruses in general, are opportunistic intracellular pathogens that rely on the host for replication and survival. They hijack the host transcription and translation machinery for their J o u r n a l P r e -p r o o f

To study the origins of COVID-induced autoAg alterations, we examined DS-affinity proteins that are involved in the interactomes of SARS-CoV-2 viral proteins [18, 29, 33] and found 38 DS-affinity proteins that interact directly with different viral proteins, with 25 of them being known autoAgs, e.g., ATP5B, CANX, DDX21, EEF1A2, PDIA3, and SLC2A1 (Table 1 ). Orf3 protein is the most striking, as its interactome includes 14 DS-affinity proteins and 9 known autoAgs. N protein interacts with 9 DS-affinity proteins and 6 known autoAgs, including 2 helicases (DDS21 and MOV10), 2 poly(A)-binding proteins (PABPC1 and PABPC4). Nsp4 interact with 6 DS-affinity proteins and 5 known autoAgs. Nsp4 interacts with IDE (insulin degrading enzyme), which is not a known autoAg.

A few host DS-affinity proteins interact with more than one SARS-CoV-2 protein. RAB1A (involved in intracellular membrane trafficking) interacts with 3 viral proteins (Orf3, Orf7b, and Nsp7), and PLD3

(phospholipase) also interacts with 3 viral proteins (Nsp2, Orf7b, and Orf8), but neither RAB1A nor PLD3 has been discovered as autoAgs. HSPA5 (GRP78/BiP) interacts with Nsp2 and Nsp4, HSPA1A interacts with N and Orf9b, and both heat shock proteins are known autoAg. PRKDC, a known autoAg, interacts with M and Nsp. Interestingly, of the ezrin-radixin-moesin protein family that connects the actin cytoskeleton to the plasma membrane, RDX is found to interact with Orf3 and Nsp13, MSN interacts with Orf3 and Nsp6, and EZR is COVID-altered. Furthermore, RDX, MSN, and EZR are all known autoAgs (Table 1) .

To find out how individual SARS-CoV-2 proteins affect the host, Stukalov et al. conducted extensive proteomic analysis of A549 cells transduced to express individual SARS-CoV-2 proteins [33] . By comparing with their data, we identified 167 In total, Orf3 affected 71 DS-affinity proteins identified from A549 cells, which includes those directly interacting with Orf3 and those perturbed by Orf3 protein expression in A549 cells. The large number of J o u r n a l P r e -p r o o f Orf3-affected host proteins implicates important roles of Orf3 in SARS-CoV-2 infection. Network analysis reveals these proteins to be mostly associated with gene expression regulation, cytoplasmic vesicles, apoptosis, response to stress, monosaccharide biosynthesis, or hydrolase activity (Fig. 5) . Several of these are classical nuclear autoAgs, e.g., PNCA, SSB (Lupus La), XRCC5 (Lupus Ku80, thyroid-lupus autoAg), XRCC6 (Ku70), and SNRPB (SmB/B'). A few are unknown autoAgs but with important relevance to COVID, e.g., PAFAH1B2 and PAFAH1B3 (the alpha catalytic subunits of the cytosolic type I plateletactivating factor (PAF) acetylhydrolase). PAF is produced by a variety of cells involved in host defense, and PAF signaling can trigger inflammatory and thrombotic cascades. The modulation of PAF by SARS-CoV-2 Orf3 may partially explain the frequently occurring thrombotic complications and coagulopathy in COVID-19 patients. PAF also induces apoptosis in a PAF receptor independent pathway that can be inhibited by PAFAH1B2 and PAFAH1B3 [39] .

SARS-CoV-2 E protein affects a number of ribonucleoproteins that are related to translation initiation and mRNA splicing, e.g., hnRNP (U and UL1) and ribosomal protein (L7, L8 L11, L12, L35A). E-affected proteins are associated with establishment of protein localization to membrane, regulation of autophagy, and post-translational protein modification (Fig. 5 ). SARS-CoV-2 M, Nsp1, and N proteins also affect various ribonucleoproteins, whereas Nsp13 appears to affect proteins associated with the cytoskeleton. Overall, the majority of DS-affinity proteins found affected by individual SARS-CoV-2 proteins are known autoAgs ( Fig. 5 and Table 1 ), which indicates that host proteins perturbed by viral components are an important source of autoAgs.

By DS-affinity fractionation, we identified 22 mitochondrial ribosomal proteins from A549 cells with strong DS-affinity, including mitochondrial 39S ribosomal proteins (L1, L2, L13, L15, L17, L18, L19, L23, L37, L38, L39, L45, L49) and 28S ribosomal proteins (S9, S22, S23, S27, S28, S29, S30, S34, S39) (Table 1) .

Remarkably, 14 mitochondrial ribosomal proteins are found down-regulated in SARS-CoV-2 infection, with 2 (L15 and L37) reported both down-and up-regulated. Moreover, MRPS27 is found in the interactome of SAS-Cov-2 Nsp8. Most strikingly, Orf9b-expression in A549 cells caused down-regulation of 16 proteins that we identified by DS-affinity, namely, ALB, ANXA4, LAMP2, MRPL2, MRPL13, MRPL15, MRPL17, MRPL18, MRPL19, MRPS30, MRPL37, MRPL38, MRPL39, MRPL45, MRPL49, and UCHL1 (Fig. 5) .

Eleven of the Orf9-affected proteins are mitochondrial ribosomal proteins, which may affect the mitochondrial translation machinery. Orf9-affected proteins may also be involved in mitochondrion J o u r n a l P r e -p r o o f localization, autophagosome maturation, or other processes. Overall, these findings suggest that SARS-CoV-2 infection may affect mitochondria primarily through Orf9b.

Orf9b of SARS-CoV has been shown to localize to mitochondria, trigger ubiquitination and proteasomal degradation of dynamin-like protein 1, limit host cell interferon signaling by targeting mitochondrial associated adaptor molecule MAVS signalosome, and manipulate the mitochondrial function to help evade host innate immunity [40] . Orf9b of SARS-CoV-2 has been reported to suppress the type I interferon response by targeting TOM70 [41] . In COVID-19 pneumonia patients, monocytes show altered bioenergetics and mitochondrial dysfunction with depolarized and abnormal ultrastructure [42] .

Currently, little is known about the involvement of mitochondrial ribosomes or mitochondrial translation in SARS-CoV-2 infection. Expression of mitochondrial ribosomal proteins associated with protein synthesis has been found to be the most striking transcriptional difference among dengue virusinfected children, as revealed by a genome-wide microarray analysis of whole blood RNA from 34 infected children collected on days 3-6 of illness [43] . In human cytomegalovirus infection, proteins involved in biogenesis of the mitochondrial ribosome changed early during the viral replication cycle [44] . Mitochondria are vital to cell survival and apoptosis as they produce the majority of adenosine triphosphate (ATP) that provide chemical energy to cells. Especially for cells such as muscles that require much ATP, mitochondrial dysfunction will certainly lead to problems such as muscle weakness and fatigue. The roles of mitochondrial ribosomal proteins play in COVID and long-term sequelae merit further investigation.

Ubiquitination provides a universal signal for protein degradation. By comparing our data with the ubiquitinome of SARS-CoV-2 infected cells, we identified 102 DS-affinity proteins that are altered by ubiquitination during viral infection (Supplemental Table 1 ). These ubiquitination-altered proteins are significantly associated with gene expression, catabolic process, regulation of apoptotic process, cytoplasmic vesicles, and cytoskeleton ( Fig. 6 ). They include 15 ribosomal proteins, 8 heat shock proteins, 5 hnRNP proteins, 5 histones, 4 translation elongation factors, and 3 translation initiation factors, and a majority of them are known autoAgs (Table 1) .

J o u r n a l P r e -p r o o f Three ubiquitination/de-ubiquitination enzymes (UBA1, UCHL1, and USP7) are COVID-altered and possess DS-affinity, with UBA1 and UCHL1 being known autoAgs. UBA1 catalyzes the first step in ubiquitin conjugation to mark proteins for degradation through the ubiquitin-proteasome system. USP7 is a hydrolase that deubiquitinates target proteins. UCHL1 is a thiol protease that recognizes and hydrolyzes a peptide bond at the C-terminal glycine of ubiquitin, and is involved in the processing of ubiquitin precursors and of ubiquitinated proteins. UBA1 is found down-regulated by Orf3 expression. UCHL1 is found in the Orf3 interactome, up-regulated by SARS-CoV-2 E protein expression, and downregulated by Nsp12, Nsp8, Orf8, and Orf9b (Supplemental Table 1 ).

Ten COVID-altered DS-affinity proteins were identified with ubiquitin protein ligase-binding activity, including HSPA1A, HSPA5, HSPA8, HSP90AA1, HSP90AB1, RPL11, VCP, VCL, YWHAE, and YWHAZ.

HSPA1A interacts with SARS-CoV-2 Orf9b and N proteins, HSPA5 (GRP78/BiP) interacts with Nsp2 and Nsp4, and HSPA8 interacts with Nsp2. Except for RPL11, all are known autoAgs (Table 1 ).

In addition, SARS-CoV-2 and other coronaviruses encode for papain-like proteases (PLP), an important multifunctional enzyme with de-ubiquitination, de-ISGlation, and interferon antagonism activities [45] .

PLPs, along with other proteases, are responsible for processing replicase proteins that are required from viral replication. PLP of SARS-CoV-2 is able to reverse host ubiquitination and remove interferonstimulated gene product 15 (ISG15), and its substrate activity mirrors closely that of PLP of MERS [46] .

Ubiquitin modifications can regulate innate immune response and apoptosis, and ISG15 is a ubiquitinlike modifier typically expressed during host cell immune response. Overall, various components of SARS-CoV-2 appear to be able to alter uniquitination of host proteins. The large pool of ubiquitin-altered proteins in SARS-CoV-2 infection indicates that ubiquitin modification, such as differential abundance and dynamic ubiquitination pattern change, may be a major origin of autoAgs.

Comparing our data with currently available phosphoproteome data of COVID-19 [25, 33] , 97 phosphoproteins are found with both DS-affinity and COVID-induced alteration, with a majority (52/97) related to gene expression (Fig. 7) . Notably, they include 8 heterogeneous nuclear ribonucleoproteins affected by phosphorylation (HNRNPA2B1, HNRNPC, HNRNPH1, HNRNPK, HNRNPM, HNRNPU, HNRNPUL1, HNRNPUL2), with 4 being known autoAgs (Table 1) . HNRNPs are involved in many cellular processes, including gene transcription, cell cycle, DNA damage control, post-transcriptional J o u r n a l P r e -p r o o f modification of newly synthesized pre-mRNA, and virus replication. For example, HNRNPA2B1 displays RNA-binding affinity to murine hepatitis coronavirus via binding the viral RNA at the 3' end and modulate viral RNA synthesis [47] .

There are 25 phosphorylation-altered proteins that are related to vesicle-mediated transport, most of which are known autoAgs, including ACLY, ACTA2, ACTB, ALB, ALDO, ANXA2, FLNA, COPA, SPTAN1, SPTBN1, TLN1, TUBB4, and VCL ( Fig. 7 and Table 1 ). The coatomer, to which COPA (coatomer subunit alpha) belongs, is a cytosolic protein complex that associates with Golgi non-clathrin-coated vesicles and is required for budding from the Golgi membrane. COPA is associated with autoimmune interstitial lung, joint, and kidney disease [48] .

There are 18 phosphorylation-altered potential autoAgs with ATP binding activity, and 12 with kinase binding activity (Fig. 7) . In particular, PRKDC (DNA-dependent protein kinase catalytic subunit) is identified with strong DS-affinity and is a known autoAg. It is a serine/threonine-protein kinase that acts as a molecular sensor for DNA damage, with involvement in numerous biological processes such as DNA damage and repair, immunity, innate immunity, ribosome biogenesis, and apoptosis. PRDKC is found in the interactomes of M and Nsp4 proteins of SARS-CoV-2 and up-regulated by expression of Nsp10, Nsp9, Orf7a, or Orf7b protein in A549 cells [18, 33] . PRKDC is also found up-regulated at 0 h and 4 h in SARS-CoV-2 infected Vero E6 cells [25] and up-regulated at 24 h in SARS-CoV-2 infected Caco-2 cells [19] .

These findings suggest that phosphorylation by PRKDC plays extensive and important roles in COVID.

Proteins phosphorylated during apoptosis are common targets of autoantibodies. For example, the U1-70 snRNP autoAg undergoes specific changes in the phosphorylation/dephosphorylation balance and cellular localization during apoptosis [49] , and phosphorylated U1-snRNP complex induced by apoptosis is recognized by autoantibodies in patients with systemic lupus erythematosus [50] . A high degree of phosphorylation of SSB (lupus La autoAg) substantially diminished its poly(U) binding capacity, but its binding to human autoantibodies increased 2-fold with increased phosphorylation [51] . On the other hand, SSB autoAg has also been reported to be dephosphorylated and cleaved during early apoptosis [52] . During apoptosis, ribosomal protein P1 and P2 autoAgs are completely dephosphorylated while P0 autoAg is partially dephosphorylated [53] . Therefore, alterations in phosphorylation, either hyper-or hypo-phosphorylation, may lead to changes in self-molecules and render them autoantigenic.

J o u r n a l P r e -p r o o f Conclusion In our quest for a comprehensive autoantigen atlas for COVID-19, we report an autoantigen profile of 191 confirmed autoAgs and 150 putative autoAgs in SARS-CoV-2 infection. These proteins are initially identified from human lung epithelial A549 cells using a unique DS-affinity autoAg enrichment strategy, and then compared with currently available COVID-omics data. Our study reveals that cellular processes and components integral to viral infection are major origins of autoAgs, including gene expression, ribonucleoprotein biogenesis, translation and mitochondrial translation, vesicle and vesicle-mediated transport, and cytoskeleton. Ubiquitination and phosphorylation are particular post-translational modifications that cause changes in self-molecules and render them autoantigenic. Impaired clearance of apoptotic and dead cell material is considered a major pathogenic attribute to autoimmune disease.

We have previously shown that DS possesses unique affinity to apoptotic cells and their released autoAgs, and our current study further demonstrates that ubiquitination and phosphorylation associated with apoptosis are possibly major sources of molecular alterations in self-molecule to autoantigen transformation. Overall, our study demonstrates that SARS-CoV-2 causes extensive alterations of host cellular proteins and produces a large number of potential autoAgs, indicating that there may be an intimate relationship between COVID infection and autoimmunity. Our data provide a deep and comprehensive atlas of autoantigens related to COVID and provide a powerful resource for ongoing studies into the pathophysiology and mechanisms of long-term autoimmune sequelae after acute COVID.

We thank Jung-hyun Rho for technical assistance with experiments. We thank Ross Tomaino and the Taplin Biological Mass Spectrometry facility of Harvard Medical School for expert service with protein sequencing.

This work was partially supported by Curandis, the US NIH, and a Cycle for Survival Innovation Grant (to MHR). MHR acknowledges the NIH/NCI R21 CA251992 and MSKCC Cancer Center Support Grant P30

CA008748. The funding bodies were not involved in the design of the study and the collection, analysis, and interpretation of data.

JYW is the founder and Chief Scientific Officer of Curandis. WZ was supported by the NIH and declares no competing interests. MWR and VBR are volunteers of Curandis. MHR is a member of the Scientific Advisory Boards of Trans-Hit, Proscia, and Universal DX, but these companies have no relation to the study.

JYW directed the study, analyzed data, and wrote the manuscript. WZ performed some experiments and reviewed the manuscript. MWR and VBR assisted with data analysis and manuscript preparation. MHR consulted on the study and data analysis and edited the manuscript. All authors have approved the manuscript.

J o u r n a l P r e -p r o o f , monosaccharide biosynthetic process (blue), response to stress (brown), and hydrolase activity (gold). Orf9b: mitochondrial translation (red), mitochondrion localization (pink), autophagosome maturation (gold). E: establishment of protein localization to membrane (red), translation initiation (pink), mRNA splicing (green), regulation of macroautophagy (brown), post-translational protein modification (gold), RNA polymerase II transcription (blue). M: establishment of protein localization to membrane (red), intracellular protein transport (gold), organelle organization (green), nicotinamide nucleotide metabolic process (aqua), regulation of apoptotic process (blue), and symbiont process (pink). N: maintenance of location in cell (pink), protein localization to ER (red), protein folding (aqua), mitochondrial nucleoid (amber), RNA polymerase II transcription (blue), and RNA-binding (green). Nsp1: protein localization (green), gene expression (red), protein processing in ER (blue), and phagosome (gold). Nsp13: cytoskeleton (gold), regulation of muscle contraction (green), and melanosome (brown). J o u r n a l P r e -p r o o f 

An Autoantigen Atlas from Human Lung HFL1 Cells Offers Clues to Neurological and Diverse Autoimmune Manifestations of COVID-19

Dermatan sulfate interacts with dead cells and regulates CD5(+) B-cell fate: implications for a key role in autoimmunity

Human proteins with affinity for dermatan sulfate have the propensity to become autoantigens

Dermatan Sulfate Is a Potential Master Regulator of IgH via Interactions with Pre-BCR, GTF2I, and BiP ER Complex in Pre-B Lymphoblasts

A proteomic repertoire of autoantigens identified from the classic autoantibody clinical test substrate HEp-2 cells

A comprehensive autoantigen-ome of autoimmune liver diseases identified from dermatan sulfate affinity enrichment of liver tissue proteins

A repertoire of 124 potential autoantigens for autoimmune kidney diseases identified by dermatan sulfate affinity enrichment of kidney tissue proteins

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis and Myelitis in COVID-19

Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19

Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C)

Serological, and Histopathological Similarities Between Severe COVID-19 and Acute Exacerbation of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD)

Prevalence of autoantibody responses in acute coronavirus disease 2019 (COVID-19)

High levels of anti-SSA/Ro antibodies in COVID-19 patients with severe respiratory failure: a case-based review : High levels of anti-SSA/Ro antibodies in COVID-19

Detection of anti-heparin-PF4 complex antibodies in COVID-19 patients on heparin therapy

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Metascape provides a biologist-oriented resource for the analysis of systems-level datasets

Single-cell landscape of immunological responses in patients with COVID-19

Comparative Multiplexed Interactomics of SARS-CoV-2 and Homologous Coronavirus Nonstructural Proteins Identifies Unique and Shared Host-Cell Dependencies

Growth Factor Receptor Signaling Inhibition Prevents SARS-CoV-2 Replication

Comparative Transcriptome Analysis Reveals the Intensive Early Stage Responses of Host Cells to SARS-CoV-2 Infection

Proteomics of SARS-CoV-2-infected host cells reveals therapy targets

A singlecell atlas of the peripheral immune response in patients with severe COVID-19

In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age

Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing

The Global Phosphorylation Landscape of SARS-CoV-2 Infection

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

Proteomic and Metabolomic Characterization of COVID-19

SARS-CoV-2 productively infects human gut enterocytes

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients. Emerging microbes & infections

Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures

Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells. Emerging microbes & infections

Multi-level proteomics reveals host-perturbation strategies of SARS-CoV-2 and SARS-CoV. bioRxiv : the preprint server for biology

Bulk and single-cell gene expression profiling of SARS-CoV-2 infected human cell lines identifies molecular targets for therapeutic intervention. bioRxiv : the preprint server for biology

Urine Proteome of COVID-19 Patients

Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19

STRING v11: proteinprotein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets

ShinyGO: a graphical gene-set enrichment tool for animals and plants

Anti-apoptotic actions of the platelet-activating factor acetylhydrolase I alpha2 catalytic subunit

Shelhamer et al. SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS/TRAF3/TRAF6 signalosome

SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70

Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia

Gene expression patterns of dengue virus-infected children from nicaragua reveal a distinct signature of increased metabolism

Catalytic function and substrate specificity of the papain-like protease domain of nsp3 from the Middle East respiratory syndrome coronavirus

Characterization and Noncovalent Inhibition of the Deubiquitinase and deISGylase Activity of SARS-CoV-2 Papain-Like Protease

Multiple type A/B heterogeneous nuclear ribonucleoproteins (hnRNPs) can replace hnRNP A1 in mouse hepatitis virus RNA synthesis

COPA mutations impair ER-Golgi transport and cause hereditary autoimmune-mediated lung disease and arthritis

Apoptosislinked changes in the phosphorylation status and subcellular localization of the spliceosomal autoantigen U1-70K

Association of phosphorylated serine/arginine (SR) splicing factors with the U1-small ribonucleoprotein (snRNP) autoantigen complex accompanies apoptotic cell death

Multiple phosphorylation of human SS-B/LA autoantigen and its effect on poly(U) and autoantibody binding

The La (SS-B) autoantigen, a key protein in RNA biogenesis, is dephosphorylated and cleaved early during apoptosis

Dephosphorylation of autoantigenic ribosomal P proteins during Fas-L induced apoptosis: a possible trigger for the development of the autoimmune response in patients with systemic lupus erythematosus

Alterations in antibody subclass immune reactivity to trophoblast-derived fetal fibronectin and α2-macroglobulin in women with recurrent pregnancy loss

Detection of citrate synthasereacting autoantibodies after heart transplantation: an epitope mapping study. Transplant international : official journal of the European Society for

Identification and validation of candidate biomarkers involved in human ovarian autoimmunity

The rheumatoid arthritis synovial fluid citrullinome reveals novel citrullinated epitopes in apolipoprotein E, myeloid nuclear differentiation antigen, and beta-actin

Glomerular antibodies in lupus nephritis

Alpha-fetoprotein is an autoantigen in hepatocellular carcinoma and juvenile Batten disease

Clinical features of LRP4/agrin-antibody-positive myasthenia gravis: A multicenter study

Autoimmunity in membranous nephropathy targets aldose reductase and SOD2

Autoantigens in ovarian autoimmunity associated with unexplained infertility and premature ovarian failure

Autoantibody against aldehyde dehydrogenase 2 could be a biomarker to monitor progression of Graves' orbitopathy

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie

Proteomic identification of aldolase A as an autoantibody target in patients with atypical movement disorders

Autoantibodies against BAFF, APRIL or IL21 -an alternative pathogenesis for antibody-deficiencies?

Autoantibodies targeting glomerular annexin A2 identify patients with proliferative lupus nephritis

Copa Syndrome: a Novel Autosomal Dominant Immune Dysregulatory Disease

Unique epitopes in RNA helicase II/Gu protein recognized by serum from a watermelon stomach patient

Do we need new autoantibodies in lupus? Arthritis research & therapy

Identification of autoantibodies to ECH1 and HNRNPA2B1 as potential biomarkers in the early detection of lung cancer

The Level of Autoantibodies Targeting Eukaryote Translation Elongation Factor 1 α1 and Ubiquitin-Conjugating Enzyme 2L3 in Nondiabetic Young Adults

Identification of autoantibodies elicited in a patient with prostate cancer presenting as dermatomyositis

Autoantibodies to Annexin XI-A and Other Autoantigens in the Diagnosis of Breast Cancer

20S small nuclear ribonucleoprotein U5 shows a surprisingly complex protein composition

Serum anti-EIF3A autoantibody as a potential diagnostic marker for hepatocellular carcinoma

Identification of a novel autoantigen eukaryotic initiation factor 3 associated with polymyositis

Evaluation of a panel of tumor-associated antigens in breast cancer. Cancer biomarkers : section A of Disease markers

Surface expression of a glycolytic enzyme, alpha-enolase, recognized by autoantibodies in connective tissue disorders

Autoantibody response to microsomal epoxide hydrolase in hepatitis C and A

The synaptic vesicle protein synaptotagmin associates with calcium channels and is a putative Lambert-Eaton myasthenic syndrome antigen

Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models

Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women

Identification of novel autoantigens via mass spectroscopy-based antibody-mediated identification of autoantigens (MS-AMIDA) using immune thrombocytopenic purpura (ITP) as a model disease

Circulating anti-filamin C autoantibody as a potential serum biomarker for low-grade gliomas

Combined measurement of CA 15-3 with novel autoantibodies improves diagnostic accuracy for breast cancer

Identification of target antigens of antifibroblast antibodies in pulmonary arterial hypertension

Detection of novel autoantigens in patients with recurrent miscarriage: description of an approach and preliminary findings

Anti-GAPDH Autoantibodies as a Pathogenic Determinant and Potential Biomarker of Neuropsychiatric Diseases

Identification of the novel autoantigen candidate Rab GDP dissociation inhibitor alpha in isolated adrenocorticotropin deficiency

Serological Proteome Analysis (SERPA) as a tool for the identification of new candidate autoantigens in type 1 diabetes

Dominant prostasome immunogens for sperm-agglutinating autoantibodies of infertile men

Glucose-6-phosphate isomerase variants play a key role in the generation of anti-GPI antibodies: possible mechanism of autoantibody production

Serum autoantibody against glutathione Stransferase in patients with glaucoma

Autoantibodies associated with lupus induced by diverse drugs target a similar epitope in the (H2A-H2B)-DNA complex

The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus

Autoantibodies against different histone H1 subtypes in systemic lupus erythematosus sera

Antibodies to H2a and H2b histones from the sera of HIV-infected patients catalyze site-specific degradation of these histones

Glomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo (2): Planted Antigens

Apoptosisassociated acetylation on histone H2B is an epitope for lupus autoantibodies

Antibodies against H3 and H4 histones from the sera of HIV-infected patients catalyze sitespecific degradation of these histones

Antibodies to native and citrullinated RA33 (hnRNP A2/B1) challenge citrullination as the inciting principle underlying loss of tolerance in rheumatoid arthritis

Heterogeneous nuclear ribonucleoproteins C1/C2 identified as autoantigens by biochemical and mass spectrometric methods

Heterogeneous nuclear RNPs as targets of autoantibodies in systemic rheumatic diseases

Proteomic identification of heterogeneous nuclear ribonucleoprotein K as a novel cold-associated autoantigen in patients with secondary Raynaud's phenomenon

Molecular definition of heterogeneous nuclear ribonucleoprotein R (hnRNP R) using autoimmune antibody: immunological relationship with hnRNP P

Identification of citrullinated hsp90 isoforms as novel autoantigens in rheumatoid arthritis-associated interstitial lung disease

Type 1 diabetes alters anti-hsp90 autoantibody isotype

Anti-heat shock protein 90beta antibodies are detected in patients with multiple sclerosis during remission

Autoimmunity to endoplasmic reticulum chaperone GRP94 in myasthenia gravis

Molecular markers of systemic autoimmune disorders: the expression of MHC-located HSP70 genes is significantly associated with autoimmunity development

Glucoseregulated protein 78 autoantibody associates with blood-brain barrier disruption in neuromyelitis optica

Circulating Autoantibodies in Age-Related Macular Degeneration Recognize Human Macular Tissue Antigens Implicated in Autophagy, Immunomodulation, and Protection from Oxidative Stress and Apoptosis

Development of a sensitive assay for the measurement of antibodies against heat shock protein binding protein 1 (HspBP1): increased levels of anti-HspBP1 IgG are prevalent in HIV infected subjects

Autoantibodies to the protein core of vascular basement membrane heparan sulfate proteoglycan in systemic lupus erythematosus

Use of the VH6-1 gene segment to code for anti-interleukin-18 autoantibodies in multiple sclerosis

Lattwein et al. ILF2 and ILF3 are autoantigens in canine systemic autoimmune disease

RasGAP-like protein IQGAP1 is expressed by human keratinocytes and recognized by autoantibodies in association with bullous skin disease

Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren's syndrome differ in molecular signatures and treatment perspectives

Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase

Importin beta: a novel autoantigen in human autoimmunity identified by screening random peptide libraries on phage

Autoantibody Response to ZRF1 and KRR1 SEREX Antigens in Patients with Breast Tumors of Different Histological Types and Grades

High prevalence of autoantibodies to hLAMP-2 in anti-neutrophil cytoplasmic antibody-associated vasculitis

Identification of L-plastin autoantibody in plasma of patients with non-Hodgkin's lymphoma using a proteomics-based analysis

Autismspecific maternal autoantibodies recognize critical proteins in developing brain

Autoantibodies to lamins A and C in sera of patients showing peripheral fluorescent antinuclear antibody pattern on HEP-2 cells

Autoantibodies to human nuclear lamin B2 protein. Epitope specificity in different autoimmune diseases

Cloning of novel soluble gp130 and detection of its neutralizing autoantibodies in rheumatoid arthritis

Microtubule-associated protein 1B: Novel paraneoplastic biomarker

Seroreactivity against glycolytic enzymes in inflammatory bowel disease

A novel autoantibody against moesin in the serum of patients with MPO-ANCA-associated vasculitis

Major vault protein/lung resistance related protein: a novel biomarker for rheumatoid arthritis

Non-muscle myosin as target antigen for human autoantibodies in patients with hepatitis C virus-associated chronic liver diseases

Monodisperse magnetic poly(glycidyl methacrylate) microspheres for isolation of autoantibodies with affinity for the 46 kDa form of unconventional Myo1C present in autoimmune patients

Antibodies against nucleolin in recipients of organ transplants

A distinct repertoire of autoantibodies in hepatocellular carcinoma identified by proteomic analysis

Identification of antigenic proteins associated with trichloroethylene-induced autoimmune disease by serological proteome analysis

Autoantibodies to the nuclear phosphoprotein nucleophosmin in breast cancer patients

Nodal proteins are target antigens in Guillain-Barré syndrome

Occurrence of autoantibody to protein disulfide isomerase in patients with hepatic disorder

Myasthenia gravis: analysis of serum autoantibody reactivities to 1827 potential human autoantigens by protein macroarrays

Identification and structure of activatedplatelet protein-1, a protein with RNA-binding domain motifs that is expressed by activated platelets

Autoimmune response to proteins of proliferating cell nuclear antigen multiprotein complexes in patients with connective tissue diseases

Protein disulfide isomerase A3-specific Th1 effector cells infiltrate colon cancer tissue of patients with circulating anti-protein disulfide isomerase A3 autoantibodies

Identification of novel autoantibodies for detection of malignant mesothelioma

Anti-human protein S antibody induces tissue factor expression through a direct interaction with platelet phosphofructokinase

Paraneoplastic pemphigus: a short review

Cancer in Systemic Sclerosis: Analysis of Antibodies Against Components of the Th/To Complex

Immunoproteomic identification of antigenic candidate Campylobacter jejuni and human peripheral nerve proteins involved in Guillain-Barré syndrome

Autoantibodies against cyclophilin in systemic lupus erythematosus and Lyme disease

Autoantibodies to peroxiredoxin I and IV in patients with systemic autoimmune diseases

Serum proteomic-based analysis identifying autoantibodies against PRDX2 and PRDX3 as potential diagnostic biomarkers in nasopharyngeal carcinoma

Identification of specific and common diagnostic antibody markers for gastrointestinal cancers by SEREX screening using testis cDNA phage library

Association of autoantibodies with Ku and DNA repair proteins in connective tissue diseases

Cyclic Peptide Mimotopes for the Detection of Serum Anti-ATIC Autoantibody Biomarker in Hepato-Cellular Carcinoma

Epstein-Barr virus-induced autoimmune responses. I. Immunoglobulin M autoantibodies to proteins mimicking and not mimicking Epstein-Barr virus nuclear antigen-1

Identification of heat shock protein 90 and other proteins as tumour antigens by serological screening of an ovarian carcinoma expression library

Antibody against chromatin assembly factor-1 is a novel autoantibody specifically recognized in systemic lupus erythematosus

Ezrin, radixin and moesin are possible auto-immune antigens in rheumatoid arthritis

Autoantigenicity of Ro/SSA antigen is related to a nucleocapsid protein of vesicular stomatitis virus

Autoantibodies specific for the 20-KDal ribosomal large subunit protein L12

Heterogeneity of ribosomal autoantibodies from human, murine and canine connective tissue diseases

Anti-5S RNA/protein (RNP) antibody levels correlate with disease activity in a patient with systemic lupus erythematosus (SLE) nephritis

Identification of candidate endothelial cell autoantigens in systemic lupus erythematosus using a molecular cloning strategy: a role for ribosomal P protein P0 as an endothelial cell autoantigen

Autoantibodies against eukaryotic protein L7 in patients suffering from systemic lupus erythematosus and progressive systemic sclerosis: frequency and correlation with clinical, serological and genetic parameters. The SLE Study Group

Properties of the ribosomal P2 protein autoantigen are similar to those of foreign protein antigens

Central nervous system function in systemic lupus erythematosus

A small nucleolar RNA is processed from an intron of the human gene encoding ribosomal protein S3

Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera

Human scleroderma sera contain autoantibodies to protein components specific to the U3 small nucleolar RNP complex

Autoantibodies to RuvBL1 and RuvBL2: a novel systemic sclerosis-related antibody associated with diffuse cutaneous and skeletal muscle involvement

Identification of anti-SF3B1 autoantibody as a diagnostic marker in patients with hepatocellular carcinoma

Characteristics of autoantibodies targeting 14-3-3 proteins and their association with clinical features in newly diagnosed giant cell arteritis

Biological autoimmunity screening in hepatitis C patients by anti-HepG2 lysate and anti-heat shock protein 70.1 autoantibodies. European journal of clinical microbiology & infectious diseases : official publication of the

Anti-U5 snRNP antibody as a possible serological marker for scleroderma-polymyositis overlap

Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases

Lupus autoantibodies discriminate between the highly homologous Sm polypeptides B/B' and SmN by binding an epitope restricted to B/B'

The C-terminal RG dipeptide repeats of the spliceosomal Sm proteins D1 and D3 contain symmetrical dimethylarginines, which form a major B-cell epitope for anti-Sm autoantibodies

Anti-sm autoantibodies in systemic lupus target highly basic surface structures of complexed spliceosomal autoantigens

Autoantibodies to survival of motor neuron complex in patients with polymyositis: immunoprecipitation of D, E, F, and G proteins without other components of small nuclear ribonucleoproteins

Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases

Anti-spectrin in sera containing smooth muscle autoantibodies from patients with chronic active hepatitis

Detection of red blood cell antibodies in mitogen-stimulated cultures from patients with hereditary spherocytosis

The 72-kDa component of signal recognition particle is cleaved during apoptosis

Autoimmune epitopes in messenger RNA

High prevalence of autoantibodies against the nuclear high mobility group (HMG) protein SSRP1 in sera from patients with systemic lupus erythematosus, but not other rheumatic diseases

Identification of novel non-myelin biomarkers in multiple sclerosis using an improved phage-display approach

Cleavage of transaldolase by granzyme B causes the loss of enzymatic activity with retention of antigenicity for multiple sclerosis patients

HLA-DQ genotype and biochemical characterization of anti-transglutaminase 2 antibodies in patients with type 1 diabetes mellitus in Taiwan

Novel serum autoantibodies against talin1 in multiple sclerosis: Possible pathogenetic roles of the antibodies

Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies

Tropomyosin isoforms in intestinal mucosa: production of autoantibodies to tropomyosin isoforms in ulcerative colitis

Identification and validation of novel serum markers for early diagnosis of endometriosis

Anti-endothelial cell antibodies in patients with cerebral small vessel disease

Anti-tubulin-alpha-1C autoantibody in systemic lupus erythematosus: a novel indicator of disease activity and vasculitis manifestations

Antitubulin antibodies. II. Natural autoantibodies and induced antibodies recognize different epitopes on the tubulin molecule

Identification of beta-tubulin isoforms as tumor antigens in neuroblastoma

Autoantibody to thioredoxin reductase in an ovarian cancer patient

Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis

Interactions of antisera to different Chlamydia and Chlamydophila species with the ribosomal protein RPS27a correlate with impaired protein synthesis in a human choroid plexus papilloma cell line

Specific interaction between human kinetochore protein CENP-C and a nucleolar transcriptional regulator

The clinical significance of ubiquitin carboxyl hydrolase L1 and its autoantibody in neuropsychiatric systemic lupus erythematosus

Autoantibody-targeted TAAs in pancreatic cancer: A comprehensive analysis

Anti-p97/VCP antibodies: an autoantibody marker for a subset of primary biliary cirrhosis patients with milder disease?

Autoimmunity to Vimentin Is Associated with Outcomes of Patients with Idiopathic Pulmonary Fibrosis

Isolation and characterization of cDNA encoding the 80-kDa subunit protein of the human autoantigen Ku (p70/p80) recognized by autoantibodies from patients with scleroderma-polymyositis overlap syndrome

Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associations

Autoantibody Formation and Mapping of Immunogenic Epitopes against Cold-Shock-Protein YB-1 in Cancer Patients and Healthy Controls

Autismspecific maternal autoantibodies recognize critical proteins in developing brain

A prospective cohort study of 14-3-3eta in ACPA and/or RF-positive patients with arthralgia

Thoracic Aortic Aneurysms: Identification of a Novel Autoantigen in Large Vessel Vasculitis. Arthritis & rheumatology

References for Table 1

Alterations in antibody subclass immune reactivity to trophoblast-derived fetal fibronectin and α2-macroglobulin in women with recurrent pregnancy loss

Detection of citrate synthasereacting autoantibodies after heart transplantation: an epitope mapping study. Transplant international : official journal of the European Society for

Identification and validation of candidate biomarkers involved in human ovarian autoimmunity

The rheumatoid arthritis synovial fluid citrullinome reveals novel citrullinated epitopes in apolipoprotein E, myeloid nuclear differentiation antigen, and beta-actin

Glomerular antibodies in lupus nephritis

Alpha-fetoprotein is an autoantigen in hepatocellular carcinoma and juvenile Batten disease

Clinical features of LRP4/agrin-antibody-positive myasthenia gravis: A multicenter study

Autoimmunity in membranous nephropathy targets aldose reductase and SOD2

Autoantigens in ovarian autoimmunity associated with unexplained infertility and premature ovarian failure

Autoantibody against aldehyde dehydrogenase 2 could be a biomarker to monitor progression of Graves' orbitopathy

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie

Proteomic identification of aldolase A as an autoantibody target in patients with atypical movement disorders

Autoantibodies against BAFF, APRIL or IL21 -an alternative pathogenesis for antibody-deficiencies?

Autoantibodies targeting glomerular annexin A2 identify patients with proliferative lupus nephritis

Detection of multiple annexin autoantibodies in a patient with recurrent miscarriages, fulminant stroke and seronegative antiphospholipid syndrome

Detection of antiannexin IV and V antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus

Annexin A5 and anti-annexin antibodies in patients with systemic lupus erythematosus

A case of neonatal lupus erythematosus presenting delayed dilated cardiomyopathy with circulating autoantibody to annexin A6

Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook

Identification of three new autoantibodies associated with systemic lupus erythematosus using two proteomic approaches

Epitope Mapping of SERCA2a Identifies an Antigenic Determinant That Induces Mainly Atrial Myocarditis in A/J Mice

Auto-antibodies to β-F1-ATPase and vimentin in malignant mesothelioma

Autoantigens in the trabecular meshwork and glaucoma-specific alterations in the natural autoantibody repertoire

The systemic lupus erythematosus (SLE) disease autoantigen-calreticulin can inhibit C1q association with immune complexes

Antibodies to the endoplasmic reticulum-resident chaperones calnexin, BiP and Grp94 in patients with rheumatoid arthritis and systemic lupus erythematosus

Proteomics-based identification of autoantibodies in the sera of healthy Chinese individuals from Beijing

Serum antibody response to group II chaperonin from Methanobrevibacter oralis and human chaperonin CCT

Identification of autoantibodies expressed in acquired aplastic anaemia

Human proteins with affinity for dermatan sulfate have the propensity to become autoantigens

Copa Syndrome: a Novel Autosomal Dominant Immune Dysregulatory Disease

Unique epitopes in RNA helicase II/Gu protein recognized by serum from a watermelon stomach patient

Do we need new autoantibodies in lupus? Arthritis research & therapy

Identification of autoantibodies to ECH1 and HNRNPA2B1 as potential biomarkers in the early detection of lung cancer

The Level of Autoantibodies Targeting Eukaryote Translation Elongation Factor 1 α1 and Ubiquitin-Conjugating Enzyme 2L3 in Nondiabetic Young Adults

Identification of autoantibodies elicited in a patient with prostate cancer presenting as dermatomyositis

Autoantibodies to Annexin XI-A and Other Autoantigens in the Diagnosis of Breast Cancer

20S small nuclear ribonucleoprotein U5 shows a surprisingly complex protein composition

Serum anti-EIF3A autoantibody as a potential diagnostic marker for hepatocellular carcinoma

Identification of a novel autoantigen eukaryotic initiation factor 3 associated with polymyositis

Evaluation of a panel of tumor-associated antigens in breast cancer. Cancer biomarkers : section A of Disease markers

Surface expression of a glycolytic enzyme, alpha-enolase, recognized by autoantibodies in connective tissue disorders

Autoantibody response to microsomal epoxide hydrolase in hepatitis C and A

The synaptic vesicle protein synaptotagmin associates with calcium channels and is a putative Lambert-Eaton myasthenic syndrome antigen

Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models

Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women

Identification of novel autoantigens via mass spectroscopy-based antibody-mediated identification of autoantigens (MS-AMIDA) using immune thrombocytopenic purpura (ITP) as a model disease

Circulating anti-filamin C autoantibody as a potential serum biomarker for low-grade gliomas

Combined measurement of CA 15-3 with novel autoantibodies improves diagnostic accuracy for breast cancer

Identification of target antigens of antifibroblast antibodies in pulmonary arterial hypertension

Detection of novel autoantigens in patients with recurrent miscarriage: description of an approach and preliminary findings

Anti-GAPDH Autoantibodies as a Pathogenic Determinant and Potential Biomarker of Neuropsychiatric Diseases

Identification of the novel autoantigen candidate Rab GDP dissociation inhibitor alpha in isolated adrenocorticotropin deficiency

Serological Proteome Analysis (SERPA) as a tool for the identification of new candidate autoantigens in type 1 diabetes

Dominant prostasome immunogens for sperm-agglutinating autoantibodies of infertile men

Glucose-6-phosphate isomerase variants play a key role in the generation of anti-GPI antibodies: possible mechanism of autoantibody production

Serum autoantibody against glutathione Stransferase in patients with glaucoma

Autoantibodies associated with lupus induced by diverse drugs target a similar epitope in the (H2A-H2B)-DNA complex

The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus

Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C)

Autoantibodies against different histone H1 subtypes in systemic lupus erythematosus sera

Antibodies to H2a and H2b histones from the sera of HIV-infected patients catalyze site-specific degradation of these histones

Glomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo (2): Planted Antigens

Apoptosisassociated acetylation on histone H2B is an epitope for lupus autoantibodies

Antibodies against H3 and H4 histones from the sera of HIV-infected patients catalyze sitespecific degradation of these histones

Antibodies to native and citrullinated RA33 (hnRNP A2/B1) challenge citrullination as the inciting principle underlying loss of tolerance in rheumatoid arthritis

Heterogeneous nuclear ribonucleoproteins C1/C2 identified as autoantigens by biochemical and mass spectrometric methods

Heterogeneous nuclear RNPs as targets of autoantibodies in systemic rheumatic diseases

Proteomic identification of heterogeneous nuclear ribonucleoprotein K as a novel cold-associated autoantigen in patients with secondary Raynaud's phenomenon

Molecular definition of heterogeneous nuclear ribonucleoprotein R (hnRNP R) using autoimmune antibody: immunological relationship with hnRNP P

Identification of citrullinated hsp90 isoforms as novel autoantigens in rheumatoid arthritis-associated interstitial lung disease

Type 1 diabetes alters anti-hsp90 autoantibody isotype

Anti-heat shock protein 90beta antibodies are detected in patients with multiple sclerosis during remission

Autoimmunity to endoplasmic reticulum chaperone GRP94 in myasthenia gravis

Molecular markers of systemic autoimmune disorders: the expression of MHC-located HSP70 genes is significantly associated with autoimmunity development

Glucoseregulated protein 78 autoantibody associates with blood-brain barrier disruption in neuromyelitis optica

Circulating Autoantibodies in Age-Related Macular Degeneration Recognize Human Macular Tissue Antigens Implicated in Autophagy, Immunomodulation, and Protection from Oxidative Stress and Apoptosis

Development of a sensitive assay for the measurement of antibodies against heat shock protein binding protein 1 (HspBP1): increased levels of anti-HspBP1 IgG are prevalent in HIV infected subjects

Autoantibodies to the protein core of vascular basement membrane heparan sulfate proteoglycan in systemic lupus erythematosus

Use of the VH6-1 gene segment to code for anti-interleukin-18 autoantibodies in multiple sclerosis

Lattwein et al. ILF2 and ILF3 are autoantigens in canine systemic autoimmune disease

RasGAP-like protein IQGAP1 is expressed by human keratinocytes and recognized by autoantibodies in association with bullous skin disease

Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren's syndrome differ in molecular signatures and treatment perspectives

Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase

Importin beta: a novel autoantigen in human autoimmunity identified by screening random peptide libraries on phage

Autoantibody Response to ZRF1 and KRR1 SEREX Antigens in Patients with Breast Tumors of Different Histological Types and Grades

High prevalence of autoantibodies to hLAMP-2 in anti-neutrophil cytoplasmic antibody-associated vasculitis

Identification of L-plastin autoantibody in plasma of patients with non-Hodgkin's lymphoma using a proteomics-based analysis

Autismspecific maternal autoantibodies recognize critical proteins in developing brain

Autoantibodies to lamins A and C in sera of patients showing peripheral fluorescent antinuclear antibody pattern on HEP-2 cells

Autoantibodies to human nuclear lamin B2 protein. Epitope specificity in different autoimmune diseases

Cloning of novel soluble gp130 and detection of its neutralizing autoantibodies in rheumatoid arthritis

Microtubule-associated protein 1B: Novel paraneoplastic biomarker

Seroreactivity against glycolytic enzymes in inflammatory bowel disease

A novel autoantibody against moesin in the serum of patients with MPO-ANCA-associated vasculitis

Major vault protein/lung resistance related protein: a novel biomarker for rheumatoid arthritis

Non-muscle myosin as target antigen for human autoantibodies in patients with hepatitis C virus-associated chronic liver diseases

Monodisperse magnetic poly(glycidyl methacrylate) microspheres for isolation of autoantibodies with affinity for the 46 kDa form of unconventional Myo1C present in autoimmune patients

Antibodies against nucleolin in recipients of organ transplants

A distinct repertoire of autoantibodies in hepatocellular carcinoma identified by proteomic analysis

Identification of antigenic proteins associated with trichloroethylene-induced autoimmune disease by serological proteome analysis

Autoantibodies to the nuclear phosphoprotein nucleophosmin in breast cancer patients

Nodal proteins are target antigens in Guillain-Barré syndrome

Occurrence of autoantibody to protein disulfide isomerase in patients with hepatic disorder

Myasthenia gravis: analysis of serum autoantibody reactivities to 1827 potential human autoantigens by protein macroarrays

Identification and structure of activatedplatelet protein-1, a protein with RNA-binding domain motifs that is expressed by activated platelets

Autoimmune response to proteins of proliferating cell nuclear antigen multiprotein complexes in patients with connective tissue diseases

Protein disulfide isomerase A3-specific Th1 effector cells infiltrate colon cancer tissue of patients with circulating anti-protein disulfide isomerase A3 autoantibodies

Identification of novel autoantibodies for detection of malignant mesothelioma

Anti-human protein S antibody induces tissue factor expression through a direct interaction with platelet phosphofructokinase

Paraneoplastic pemphigus: a short review

Cancer in Systemic Sclerosis: Analysis of Antibodies Against Components of the Th/To Complex

Immunoproteomic identification of antigenic candidate Campylobacter jejuni and human peripheral nerve proteins involved in Guillain-Barré syndrome

Autoantibodies against cyclophilin in systemic lupus erythematosus and Lyme disease

Autoantibodies to peroxiredoxin I and IV in patients with systemic autoimmune diseases

Serum proteomic-based analysis identifying autoantibodies against PRDX2 and PRDX3 as potential diagnostic biomarkers in nasopharyngeal carcinoma

Identification of specific and common diagnostic antibody markers for gastrointestinal cancers by SEREX screening using testis cDNA phage library

Association of autoantibodies with Ku and DNA repair proteins in connective tissue diseases

Cyclic Peptide Mimotopes for the Detection of Serum Anti-ATIC Autoantibody Biomarker in Hepato-Cellular Carcinoma

Epstein-Barr virus-induced autoimmune responses. I. Immunoglobulin M autoantibodies to proteins mimicking and not mimicking Epstein-Barr virus nuclear antigen-1

Identification of heat shock protein 90 and other proteins as tumour antigens by serological screening of an ovarian carcinoma expression library

Antibody against chromatin assembly factor-1 is a novel autoantibody specifically recognized in systemic lupus erythematosus

Ezrin, radixin and moesin are possible auto-immune antigens in rheumatoid arthritis

Autoantigenicity of Ro/SSA antigen is related to a nucleocapsid protein of vesicular stomatitis virus

Autoantibodies specific for the 20-KDal ribosomal large subunit protein L12

Heterogeneity of ribosomal autoantibodies from human, murine and canine connective tissue diseases

Anti-5S RNA/protein (RNP) antibody levels correlate with disease activity in a patient with

systemic lupus erythematosus (SLE) nephritis

Identification of candidate endothelial cell autoantigens in systemic lupus erythematosus using a molecular cloning strategy: a role for ribosomal P protein P0 as an endothelial cell autoantigen

Autoantibodies against eukaryotic protein L7 in patients suffering from systemic lupus erythematosus and progressive systemic sclerosis: frequency and correlation with clinical, serological and genetic parameters. The SLE Study Group

Properties of the ribosomal P2 protein autoantigen are similar to those of foreign protein antigens

Central nervous system function in systemic lupus erythematosus

A small nucleolar RNA is processed from an intron of the human gene encoding ribosomal protein S3

Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera

Human scleroderma sera contain autoantibodies to protein components specific to the U3 small nucleolar RNP complex

Autoantibodies to RuvBL1 and RuvBL2: a novel systemic sclerosis-related antibody associated with diffuse cutaneous and skeletal muscle involvement

Identification of anti-SF3B1 autoantibody as a diagnostic marker in patients with hepatocellular carcinoma

Characteristics of autoantibodies targeting 14-3-3 proteins and their association with clinical features in newly diagnosed giant cell arteritis

Biological autoimmunity screening in hepatitis C patients by anti-HepG2 lysate and anti-heat shock protein 70.1 autoantibodies. European journal of clinical microbiology & infectious diseases : official publication of the

Anti-U5 snRNP antibody as a possible serological marker for scleroderma-polymyositis overlap

Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases

Lupus autoantibodies discriminate between the highly homologous Sm polypeptides B/B' and SmN by binding an epitope restricted to B/B'

The C-terminal RG dipeptide repeats of the spliceosomal Sm proteins D1 and D3 contain symmetrical dimethylarginines, which form a major B-cell epitope for anti-Sm autoantibodies

Anti-sm autoantibodies in systemic lupus target highly basic surface structures of complexed spliceosomal autoantigens

Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases

Anti-spectrin in sera containing smooth muscle autoantibodies from patients with chronic active hepatitis

Detection of red blood cell antibodies in mitogen-stimulated cultures from patients with hereditary spherocytosis

The 72-kDa component of signal recognition particle is cleaved during apoptosis

Autoimmune epitopes in messenger RNA

High prevalence of autoantibodies against the nuclear high mobility group (HMG) protein SSRP1 in sera from patients with systemic lupus erythematosus, but not other rheumatic diseases

Identification of novel non-myelin biomarkers in multiple sclerosis using an improved phage-display approach

Cleavage of transaldolase by granzyme B causes the loss of enzymatic activity with retention of antigenicity for multiple sclerosis patients

HLA-DQ genotype and biochemical characterization of anti-transglutaminase 2 antibodies in patients with type 1 diabetes mellitus in Taiwan

Novel serum autoantibodies against talin1 in multiple sclerosis: Possible pathogenetic roles of the antibodies

Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies

Tropomyosin isoforms in intestinal mucosa: production of autoantibodies to tropomyosin isoforms in ulcerative colitis

Identification and validation of novel serum markers for early diagnosis of endometriosis

Anti-endothelial cell antibodies in patients with cerebral small vessel disease

Anti-tubulin-alpha-1C autoantibody in systemic lupus erythematosus: a novel indicator of disease activity and vasculitis manifestations

Antitubulin antibodies. II. Natural autoantibodies and induced antibodies recognize different epitopes on the tubulin molecule

Identification of beta-tubulin isoforms as tumor antigens in neuroblastoma

Autoantibody to thioredoxin reductase in an ovarian cancer patient

Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis

Interactions of antisera to different Chlamydia and Chlamydophila species with the ribosomal protein RPS27a correlate with impaired protein synthesis in a human choroid plexus papilloma cell line

Specific interaction between human kinetochore protein CENP-C and a nucleolar transcriptional regulator

The clinical significance of ubiquitin carboxyl hydrolase L1 and its autoantibody in neuropsychiatric systemic lupus erythematosus

Autoantibody-targeted TAAs in pancreatic cancer: A comprehensive analysis

Anti-p97/VCP antibodies: an autoantibody marker for a subset of primary biliary cirrhosis patients with milder disease?

Autoimmunity to Vimentin Is Associated with Outcomes of Patients with Idiopathic Pulmonary Fibrosis

Isolation and characterization of cDNA encoding the 80-kDa subunit protein of the human autoantigen Ku (p70/p80) recognized by autoantibodies from patients with scleroderma-polymyositis overlap syndrome

Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associations

Autoantibody Formation and Mapping of Immunogenic Epitopes against Cold-Shock-Protein YB-1 in Cancer Patients and Healthy Controls

Autismspecific maternal autoantibodies recognize critical proteins in developing brain

A prospective cohort study of 14-3-3eta in ACPA and/or RF-positive patients with arthralgia

Thoracic Aortic Aneurysms: Identification of a Novel Autoantigen in Large Vessel Vasculitis. Arthritis & rheumatology

J o u r n a l P r e -p r o o f T18